Pacer Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $325K | Buy |
|
|||||
|
2025
Q2 | $123K | Sell |
|
|||||
|
2025
Q1 | $265K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $23.3M | Buy |
|
|||||
|
2023
Q3 | $12.3M | Buy |
|
|||||
|
2023
Q2 | $9.86M | Sell |
|
|||||
|
2023
Q1 | $11.3M | Buy |
|
|||||
|
2022
Q4 | $7.49M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $5.19M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $230K | Sell |
|
|||||
|
2021
Q1 | $343K | Sell |
|
|||||
|
2020
Q4 | $318K | Sell |
|
|||||
|
2020
Q3 | $456K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $622K | Sell |
|
|||||
|
2019
Q3 | $759K | Sell |
|
|||||
|
2019
Q2 | $937K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $368K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $68K | Buy |
|